End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
85,200 KRW | -1.39% | +1.31% | -15.14% |
May. 10 | SK Biopharmaceuticals Turns to Profit in Q1 as Sales Jump 88% | MT |
Jan. 30 | SK Biopharmaceuticals Swings to Profit in Q4 | MT |
Sales 2024 * | 492B 357M | Sales 2025 * | 643B 467M | Capitalization | 6,672B 4.84B |
---|---|---|---|---|---|
Net income 2024 * | 36B 26.14M | Net income 2025 * | 118B 85.67M | EV / Sales 2024 * | 13.3 x |
Net cash position 2024 * | 121B 87.68M | Net cash position 2025 * | 218B 158M | EV / Sales 2025 * | 10 x |
P/E ratio 2024 * |
176
x | P/E ratio 2025 * |
53.1
x | Employees | 252 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 35.75% |
1 day | -1.39% | ||
1 week | +1.31% | ||
Current month | -0.23% | ||
1 month | -1.62% | ||
3 months | -7.09% | ||
6 months | -4.91% | ||
Current year | -15.14% |
Managers | Title | Age | Since |
---|---|---|---|
Dong-Hoon Lee
CEO | Chief Executive Officer | 56 | 22-12-31 |
Choi Jonggil
PRN | Corporate Officer/Principal | - | 22-12-31 |
Jeong-Woo Jo
PRN | Corporate Officer/Principal | - | 17-03-15 |
Members of the board | Title | Age | Since |
---|---|---|---|
Geun-Joo Hwang
BRD | Director/Board Member | 60 | 17-03-15 |
Jeong-Woo Jo
PRN | Corporate Officer/Principal | - | 17-03-15 |
Young-Ju Bang
BRD | Director/Board Member | - | 19-08-26 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
1.83% | 2 M€ | -14.14% | ||
0.08% | 15 M€ | +15.02% | ||
0.03% | 2,867 M€ | +8.01% | - | |
0.03% | 454 M€ | +6.23% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-06-05 | 85,200 | -1.39% | 49,644 |
24-06-04 | 86,400 | +0.70% | 81,310 |
24-06-03 | 85,800 | +0.47% | 76,528 |
24-05-31 | 85,400 | +1.55% | 203,807 |
24-05-30 | 84,100 | +1.82% | 108,328 |
End-of-day quote Korea S.E., June 04, 2024
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-15.14% | 4.89B | |
+18.60% | 81.33B | |
+14.11% | 9.14B | |
+46.88% | 4.61B | |
+15.70% | 4.36B | |
+7.59% | 2.26B | |
-27.88% | 2.15B | |
+15.73% | 2.1B | |
-43.02% | 1.78B | |
-0.50% | 1.64B |
- Stock Market
- Equities
- A326030 Stock